Founded by a Nobel Prize-winning team including Stanford M.D./Ph.D., Nobel Laureate, and a Harvard Business School/UW Madison Engineer. We are commercializing diagnostics for Cancer, Neurological, and Infectious Diseases, and are in clinical trials at Stanford University. The Diagnose Early team has patented a COVID-19 Acuity test titled D.E.C.A. that uses amino acid biomarkers found in breath to accurately and non-invasively predict the clinical course of each patient and therefore guide treatment.
Location: United States, California, Newark
Employees: 11-50
Founded date: 2017